Q2 FY2026 · ended Jun 30, 2026 · Revenue $332,000 · Filed Aug 19, 2026
BiomX Inc. (HLSQ) files with the SEC under industry code 7372, Services-Prepackaged Software. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $332,000 and a net loss of $3.8 million. Free cash flow was -$1.2 million. As of Jun 30, 2026 it held $572,000 in cash and investments and $478,000 in total debt.
Revenue
$332,000
Net income
$-3.85M
+36.3% vs year-ago quarter
Operating cash flow
$-1.17M
+80.8% vs year-ago quarter
Free cash flow
$-1.17M
+73.3% vs prior quarter
EPS
$0.37
-89.9% vs year-ago quarter
Dividend per share
None
Shares outstanding
26.72M
+0.7% vs year-ago quarter
Net cash
$94,000
Q2 FY2026
Operating margin
-1630.7%
Q2 FY2026
Company profile
- Industry
- Services-Prepackaged Software (SIC 7372)
- Listed as
- HLSQ (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Dover, DE
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1739174
- Former names
- BiomX Inc. (until Sep 9, 2026); Chardan Healthcare Acquisition Corp. (until Oct 23, 2019)
Other Services-Prepackaged Software companies
- Microsoft Corp MSFT
- Palantir Technologies Inc. PLTR
- Oracle Corp ORCL
- Sap SE SAP
- CrowdStrike Holdings, Inc. CRWD
- Shopify Inc. SHOP
- Salesforce, Inc. CRM
- ServiceNow, Inc. NOW
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $332,000 | — | — | — | — |
| Operating income | -$5.4M | -$1.3M | -$17.7M | -$8.5M | -$7.4M |
| Net income | -$3.8M | -$19.1M | -$13.3M | -$9.2M | -$6.0M |
| Diluted EPS | $0.37 | $7.38 | $0.17 | $0.29 | $3.66 |
| Operating cash flow | -$1.2M | -$5.4M | -$4.4M | -$7.2M | -$6.1M |
| Free cash flow | -$1.2M | — | -$4.4M | -$7.2M | — |
| Total assets | $28.2M | $3.3M | $5.8M | $26.2M | $38.0M |
| Total liabilities | $10.6M | $4.1M | — | — | — |
| Stockholders' equity | $10.9M | -$881,000 | -$1.3M | $10.5M | $19.2M |
| Cash and investments | $572,000 | $1.2M | $4.4M | $6.9M | $14.0M |
| Total debt | $478,000 | — | $1.4M | $6.6M | $9.4M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Unregistered share sale, Officer or director change, Shareholder vote results
|
Oct 23, 2026 | Oct 20, 2026 |
| 8-K |
Current report
Unregistered share sale
|
Oct 19, 2026 | Oct 13, 2026 |
| 8-K |
Current report
Unregistered share sale, Other events
|
Oct 13, 2026 | Oct 6, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Oct 7, 2026 | Oct 7, 2026 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Oct 5, 2026 | Sep 29, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 29, 2026 | Sep 29, 2026 |
All 582 BiomX Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.